|1.||Secchi, A: 3 articles (06/2001 - 01/2000)|
|2.||Leonardi, A: 3 articles (06/2001 - 01/2000)|
|3.||Katayama, Ichiro: 2 articles (08/2009 - 09/2003)|
|4.||Endre, László: 2 articles (02/2007 - 04/2003)|
|5.||Corrado, Mario E: 2 articles (01/2004 - 01/2004)|
|6.||Stübner, Petra: 2 articles (01/2004 - 01/2003)|
|7.||Assandri, Alessandro: 2 articles (01/2004 - 01/2004)|
|8.||Horak, Friedrich: 2 articles (01/2004 - 01/2003)|
|9.||Zieglmayer, René: 2 articles (01/2004 - 01/2003)|
|10.||Mion, Alberto: 2 articles (01/2004 - 01/2004)|
|1.||Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
05/01/2008 - "Spaglumic acid and emedastine seem to be the most useful drugs to reduce EB extravasation and allergic signs in an animal model of early phase allergic conjunctivitis."
02/11/2007 - "[The prompt effect of emedastine eye drop and the safety of its permanent use in children suffering from acute seasonal allergic conjunctivitis]."
03/01/2002 - "Emedastine is indicated for the temporary relief of the signs and symptoms of allergic conjunctivitis. "
04/01/2001 - "Emedastine and allergic conjunctivitis: new preparation. "
04/06/2003 - "It may be stated that the eyedrop containing emedastine effectively decreases the extents of itching of the eye and conjunctival hyperaemia in children with acute allergic conjunctivitis, its effects are exerted within minutes."
|2.||Seasonal Allergic Rhinitis (Hay Fever)
03/01/2002 - "Emedastine is registered in its country of origin (Japan) as an antihistamine for the indication of seasonal allergic rhinitis. "
01/01/2004 - "Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus cetirizine in the treatment of seasonal allergic rhinitis."
01/01/2004 - "The aim of this study was to evaluate the therapeutic efficacy and tolerability of emedastine difumarate (CAS 87233-62-3) in Caucasian patients in the treatment of seasonal allergic rhinitis as compared to terfenadine (CAS 50679-08-8). "
01/01/2004 - "Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus terfenadine in the treatment of seasonal allergic rhinitis."
01/01/2004 - "The therapeutic efficacy and tolerability of emedastine difumarate (CAS 87233-62-3) in male and female Caucasian patients with seasonal allergic rhinitis as compared to cetirizine (CAS 83881-51-0) was evaluated. "
02/11/2007 - "Emadine eye drop decreases the itching and the redness of the conjunctiva very quickly and effectively. "
04/06/2003 - "It was found that, after a single administration of 1 emedastine eyedrop, the degree of itching of the eye fell from the starting score of 2.85 +/- 0.75 to 0.45 +/- 0.51 within an average of 2.95 minutes, while the conjunctival hyperaemia fell from 2.35 +/- 0.59 to 0.55 +/- 0.51 in an average of 7.7 minutes. "
01/01/2001 - "From day 7 to 42, patients treated with emedastine had less itching (p < 0.001) and less redness (p < 0.001). "
01/01/2000 - "Emedastine was also significantly better at reducing redness and itching at Days 7, 14, 30 and 42 (p < 0.05). "
01/01/1999 - "Emedastine significantly (p < 0.05) inhibited ocular itching and redness in vascular beds following topical ocular administration. "
02/01/1987 - "These results suggest that KB-2413 strongly suppresses type I allergic reactions, and it slightly suppresses type II, III and IV allergic reactions."
02/01/1987 - "The effects of KB-2413 on four types of allergic reactions classified by Coombs and Gell were investigated. "
01/01/2000 - "In a randomized, double-masked, parallel controlled study, emedastine ophthalmic solution 0.05% BID was compared to levocabastine ophthalmic suspension 0.05% BID for control of chemosis, eyelid swelling and other parameters in the environmental allergy study model. "
01/01/2004 - "To determine, whether the immediately originated allergic reaction of conjunctivas may be treated with local H1 antihistaminic drugs in a monotherapy (Allergodil gtt, Emadine gtt). "
02/01/1987 - "KB-2413 had an inhibitory effect on the efferent phase of delayed-type hypersensitivity induced by picryl chloride (PC-DTH) in mice. "
01/01/2004 - "The results of study show that emedastine difumarate is more effective than terfenadine in the symptomatic management of seasonal allergic rhinitis and is particularly active in controlling the main nasal symptoms, such as sneezing and rhinorrhea; it is safe and well tolerated in this therapeutic indication, while related AEs are less if compared to those displayed by terfenadine."
|1.||Ophthalmic Solutions (Eye Drops)